Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
Glide Pharma: The Transition from Drug Delivery to Specialty




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Glide Pharma: The Transition from Drug Delivery to Specialty
Released on: February 01, 2007. © PharmaVentures Ltd
Visitors: You are watching a 5 minute preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Fintan Walton talks to Charles Potter, CEO, Glide Pharma, about inventing the Glide technology and his subsequent setting up of Glide Pharmaceutical Technologies.
  • Summary
  • Transcript
  • Participants
  • Company
Fintan Walton talks to Charles Potter, CEO, Glide Pharma, about inventing the Glide technology and his subsequent setting up of Glide Pharmaceutical Technologies. After covering Charles’ experience at PowderJect Pharmaceuticals, Fintan and Charles discuss how the company, originally set up as the drug delivery firm Caretek Medical, evolved into a specialty pharmaceutical company. Today, Glide Pharma has three generic products in its pipeline, in addition to partnerships that include one with a top five pharmaceutical company. These applications of the Glide technology have been applied only to products already available on the market, but this may change as the company moves forward.

Glide’s financial backing includes support from Oxford Venture Capital Trust and other local business angels. Impressively, the last equity financing closed just 4 weeks after the business plans were sent out! Glide is obviously in a good position at the moment, and expects to raise further finance after completing some internal company milestones. The opportunities for Glide at the moment are enormous. In addition to it own products and partnerships, the company’s technology patent also permits it application to medical devices. For the time being, however, Glide intends to focus its efforts on its current projects.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Charles Potter founded Caretek Medical, now known as Glide Pharma, in 2001, following the invention of the Glide ™ (then ImplaJect ®) technology - a novel needle-free drug delivery technology for the injection of drugs and vaccines in a solid dosage form. Charles has worked in four other successful start-up companies, including nearly six years at PowderJect Pharmaceuticals, where he saw the company grow from just five employees to over 1000.

Charles holds an engineering degree and PhD from Cambridge University. He also spent 6 years undertaking research within the Transplant Unit at Papworth Hospital, a specialist cardiothoracic centre, where he gained extensive medical experience.
Glide Pharma